Jin-Kyu Baek

Baek’s notable matters include representing:

• Disney in its $85 billion acquisition of 21st Century Fox;
  
  
• Kenvue in its pending $48.7 billion acquisition by Kimberly‑Clark and its cooperation agreement with Starboard;

• Viacom’s transaction committee in the $30 billion merger with CBS;

• The special committee of the board of directors of EchoStar in the $26 billion combination with DISH Network;
  
  
• Johnson & Johnson in its $16.6 billion acquisition of Abiomed, its $14.6 billion acquisition of Intra‑Cellular Therapies, its $6.5 billion acquisition of Momenta, the $2.1 billion sale of LifeScan to Platinum Equity, its $2 billion acquisition of Ambrx and Janssen’s $750 million acquisition of bermekimab from XBiotech;

• CyrusOne in its $15 billion acquisition by KKR and Global Infrastructure Partners;
  
  
• Aon in its $13 billion acquisition of NFP;

• Amazon in its $8.45 billion acquisition of MGM;

• AmerisourceBergen in its $6.5 billion acquisition of Walgreens’ Alliance Healthcare businesses;

• Cano Health shareholders, including members of management, in the $4.4 billion SPAC merger with Jaws Acquisition Corp., including an $800 million PIPE investment;
  
  
• Thermo Fisher Scientific in its $3.1 billion acquisition of Olink;
  
  
• Consolidated Communications’ special committee in the $3.1 billion acquisition by Searchlight and BCI;
  
  
• Radius Global Infrastructure in its $3 billion acquisition by EQT Active Core Infrastructure and PSP Investments;

• Roivant Sciences in its $3 billion Strategic Alliance with Sumitomo Dainippon Pharma;
  
  
• IBM in its €2.13 billion acquisition of the StreamSets and webMethods platforms from Software AG;
  
  
• Star Bulk in its $2.1 billion combination with Eagle Bulk Shipping;

• FactSet in its $1.925 billion acquisition of CUSIP Global Services from S&P Global, its $246.5 million acquisition of LiquidityBook and its acquisition of Irwin;

• OneBeacon Insurance and White Mountains Insurance in the $1.7 billion sale of OneBeacon Insurance to Intact Financial;

• Ashland in the $1.65 billion sale of its performance adhesives business to Arkema and the sale of its nutraceuticals business to Turnspire Capital Partners;

• ADT in its $1.2 billion equity investment from State Farm;

• Sobi in its $915 million acquisition of Dova;
  
  
• Light & Wonder in its $850 million acquisition of Grover Charitable Gaming;

• Pitney Bowes in the $700 million sale of its Software Solutions business to Syncsort;

• Prosus in its $500 million PIPE investment in connection with Churchill II SPAC’s $1.5 billion merger with Skillsoft and acquisition of Global Knowledge;

• US Foods in its $500 million convertible preferred equity investment from KKR;

• BAF in Lindsay Goldberg’s sale of BAF to Madison IAQ;
  
  
• Costamare in the spin-off of Costamare Bulkers;

• Evergy in its agreements with Elliott Management and Bluescape Energy Partners;

• GasLog Ltd. in its acquisition of GasLog Partners and its take‑private transaction with BlackRock’s Global Energy & Power Infrastructure Fund;

• J.D. Power in its sale to Thoma Bravo;
  
  
• Jefferies in the significant expansion of its Global Strategic Alliance with SMBC Group—which includes a joint venture combining their Japanese equities and ECM businesses, and an increase in SMBC’s equity ownership in Jefferies to up to 20%—and in the previous expansion that included a total commitment of up to $3.4 billion to Jefferies by SMBC;

• KKR’s board committee in KKR’s conversion to a corporation; 
  
  
• Montana Technologies in its joint venture with GE Vernova; and 

• Univision in its sale of a majority stake to Searchlight and ForgeLight.